Recently, Cohen et al.[50] mapped patterns of epigenetic pathway activation in breast and other tumor types and identified a gene expression pattern of EZH2 activation in luminal breast tumors, and HDAC4 pathway activation was seen in basal breast tumors. This evidence concerns the gene HDAC4 and breast neoplasm.